Class information for:
Level 1: ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
12327 914 44.3 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
110 3       PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER 71389
617 2             ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA 13940
12327 1                   ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE 914

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ARIPIPRAZOLE authKW 2542272 28% 30% 253
2 BLONANSERIN authKW 626359 3% 63% 30
3 CONDITIONED AVOIDANCE RESPONSE authKW 601728 4% 49% 37
4 DEHYDROARIPIPRAZOLE authKW 508134 2% 89% 17
5 PEROSPIRONE authKW 484993 3% 52% 28
6 OPC 14597 authKW 237559 1% 89% 8
7 BREXPIPRAZOLE authKW 209090 1% 48% 13
8 SM 9018 authKW 171806 1% 86% 6
9 BIFEPRUNOX authKW 169115 1% 56% 9
10 NEUROBIOL 2 address 164943 2% 25% 20

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Psychiatry 10569 39% 0% 355
2 Pharmacology & Pharmacy 10174 61% 0% 556
3 Neurosciences 3340 36% 0% 329
4 Clinical Neurology 1123 16% 0% 150
5 Behavioral Sciences 634 6% 0% 58
6 Chemistry, Medicinal 212 5% 0% 48
7 Psychology, Clinical 85 3% 0% 24
8 Substance Abuse 62 1% 0% 13
9 Toxicology 58 3% 0% 29
10 Medical Laboratory Technology 37 1% 0% 12

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEUROBIOL 2 164943 2% 25% 20
2 QUESTS 92793 1% 56% 5
3 QS 60617 1% 26% 7
4 NEW DRUG DISCOVERY 2 54657 1% 27% 6
5 ALCOHOL DEPENDENCE 44541 0% 67% 2
6 CNRSFRE 3006 44541 0% 67% 2
7 PHARMACOECON SOCIAL PHARM 40079 1% 20% 6
8 ACUTE PSYCHIAT CARE SERV 33407 0% 100% 1
9 AMBULATORY CARE PAVIL 33407 0% 100% 1
10 ARIPIPRAZOLE PROJECT 33407 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 6815 2% 1% 19
2 PSYCHOPHARMAKOTHERAPIE 6702 1% 2% 10
3 PSYCHOPHARMACOLOGY 5803 5% 0% 46
4 JOURNAL OF PSYCHOPHARMACOLOGY 5243 2% 1% 19
5 CNS DRUGS 4875 2% 1% 16
6 BEHAVIOURAL PHARMACOLOGY 4383 2% 1% 16
7 NEUROPSYCHOPHARMACOLOGY 4082 3% 0% 25
8 PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 3576 3% 0% 23
9 EUROPEAN JOURNAL OF PHARMACOLOGY 3156 6% 0% 52
10 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 2397 2% 1% 14

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ARIPIPRAZOLE 2542272 28% 30% 253 Search ARIPIPRAZOLE Search ARIPIPRAZOLE
2 BLONANSERIN 626359 3% 63% 30 Search BLONANSERIN Search BLONANSERIN
3 CONDITIONED AVOIDANCE RESPONSE 601728 4% 49% 37 Search CONDITIONED+AVOIDANCE+RESPONSE Search CONDITIONED+AVOIDANCE+RESPONSE
4 DEHYDROARIPIPRAZOLE 508134 2% 89% 17 Search DEHYDROARIPIPRAZOLE Search DEHYDROARIPIPRAZOLE
5 PEROSPIRONE 484993 3% 52% 28 Search PEROSPIRONE Search PEROSPIRONE
6 OPC 14597 237559 1% 89% 8 Search OPC+14597 Search OPC+14597
7 BREXPIPRAZOLE 209090 1% 48% 13 Search BREXPIPRAZOLE Search BREXPIPRAZOLE
8 SM 9018 171806 1% 86% 6 Search SM+9018 Search SM+9018
9 BIFEPRUNOX 169115 1% 56% 9 Search BIFEPRUNOX Search BIFEPRUNOX
10 ANTIPSYCHOTICS 164445 17% 3% 153 Search ANTIPSYCHOTICS Search ANTIPSYCHOTICS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NEWMAN-TANCREDI, A , KLEVEN, MS , (2011) COMPARATIVE PHARMACOLOGY OF ANTIPSYCHOTICS POSSESSING COMBINED DOPAMINE D-2 AND SEROTONIN 5-HT1A RECEPTOR PROPERTIES.PSYCHOPHARMACOLOGY. VOL. 216. ISSUE 4. P. 451 -473 84 42% 69
2 DE BARTOLOMEIS, A , TOMASETTI, C , IASEVOLI, F , (2015) UPDATE ON THE MECHANISM OF ACTION OF ARIPIPRAZOLE: TRANSLATIONAL INSIGHTS INTO ANTIPSYCHOTIC STRATEGIES BEYOND DOPAMINE RECEPTOR ANTAGONISM.CNS DRUGS. VOL. 29. ISSUE 9. P. 773 -799 65 35% 9
3 NEWMAN-TANCREDI, A , (2010) THE IMPORTANCE OF 5-HT1A RECEPTOR AGONISM IN ANTIPSYCHOTIC DRUG ACTION: RATIONALE AND PERSPECTIVES.CURRENT OPINION IN INVESTIGATIONAL DRUGS. VOL. 11. ISSUE 7. P. 802-812 42 52% 73
4 CACCIA, S , (2011) PHARMACOKINETICS AND METABOLISM UPDATE FOR SOME RECENT ANTIPSYCHOTICS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 7. ISSUE 7. P. 829 -846 41 55% 11
5 NEWMAN-TANCREDI, A , CUSSAC, D , DEPOORTERE, R , (2007) NEUROPHARMACOLOGICAL PROFILE OF BIFEPRUNOX: MERITS AND LIMITATIONS IN COMPARISON WITH OTHER THIRD-GENERATION ANTIPSYCHOTICS.CURRENT OPINION IN INVESTIGATIONAL DRUGS. VOL. 8. ISSUE 7. P. 539-554 46 51% 39
6 SOPONAR, F , SANDRU, M , DAVID, V , (2014) QUANTITATIVE EVALUATION OF ARIPIPRAZOLE AND ITS FIVE RELATED CHEMICAL IMPURITIES FROM PHARMACEUTICALS USING A HPLC-DAD METHOD.REVUE ROUMAINE DE CHIMIE. VOL. 59. ISSUE 11-12. P. 1037 -1046 22 96% 1
7 GAO, J , QIN, RY , LI, M , (2015) REPEATED ADMINISTRATION OF ARIPIPRAZOLE PRODUCES A SENSITIZATION EFFECT IN THE SUPPRESSION OF AVOIDANCE RESPONDING AND PHENCYCLIDINE-INDUCED HYPERLOCOMOTION AND INCREASES D-2 RECEPTOR-MEDIATED BEHAVIORAL FUNCTION.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 29. ISSUE 4. P. 390 -400 35 57% 1
8 NEWMAN-TANCREDI, A , ASSIE, MB , LEDUC, N , ORMIERE, AM , DANTY, N , COSI, C , (2005) NOVEL ANTIPSYCHOTICS ACTIVATE RECOMBINANT HUMAN AND NATIVE RAT SEROTONIN 5-HT1A RECEPTORS: AFFINITY, EFFICACY AND POTENTIAL IMPLICATIONS FOR TREATMENT OF SCHIZOPHRENIA.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. VOL. 8. ISSUE 3. P. 341-356 37 61% 88
9 MCCREARY, AC , JONES, CA , (2010) ANTIPSYCHOTIC MEDICATION: THE POTENTIAL ROLE OF 5-HT1A RECEPTOR AGONISM.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 5. P. 516-521 40 52% 18
10 JONES, CA , MCCREARY, AC , (2008) SEROTONERGIC APPROACHES IN THE DEVELOPMENT OF NOVEL ANTIPSYCHOTICS.NEUROPHARMACOLOGY. VOL. 55. ISSUE 6. P. 1056-1065 56 38% 30

Classes with closest relation at Level 1


Rank Class id link
1 20744 ASENAPINE//ZIPRASIDONE//LURASIDONE
2 10822 AMPEROZIDE//CLOZAPINE//SAVOXEPINE
3 12452 OSU6162//ROXINDOLE//TERGURIDE
4 3313 DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT
5 1348 AMISULPRIDE//ANTIPSYCHOTICS//CLOZAPINE
6 31207 SUPERSENSITIVITY PSYCHOSIS//4 OXAZEPINE DERIVATIVES//CODED INACTIVE MEDICATION
7 3624 5 HT1A RECEPTOR//BUSPIRONE//8 OH DPAT
8 18005 ARYLPIPERAZINES//5 HT1A LIGANDS//LONG CHAIN ARYLPIPERAZINES
9 7609 9 HYDROXYRISPERIDONE//NORCLOZAPINE//CLOZAPINE
10 17531 VACUOUS CHEWING MOVEMENTS//TARDIVE DYSKINESIA//OROFACIAL DYSKINESIA

Go to start page